Embecta (EMBC) FCF Payout Ratio Growth (1y) (2023 - 2026)
Embecta (EMBC) FCF Payout Ratio Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 39.78% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 41.36% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -94.63% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 31.13% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -94.57% |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | -86.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -86.31% |
| Mar 31, 2026 | 5.98% |
| Dec 31, 2025 | 141.43% |
| Sep 30, 2025 | -64.92% |
| Jun 30, 2025 | 114.77% |
| Mar 31, 2025 | -33.30% |
| Dec 31, 2024 | -137.76% |
| Sep 30, 2024 | -22.42% |
| Jun 30, 2024 | -36.44% |
| Mar 31, 2024 | 189.95% |
| Dec 31, 2023 | -452.53% |
| Sep 30, 2023 | 142.16% |